共 556 条
[1]
Jemal A(2007)Cancer statistics, 2007 CA Cancer J Clin 57 43-66
[2]
Siegel R(2003)Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 J Clin Oncol 21 1431-1439
[3]
Ward E(1990)Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16 J Clin Oncol 8 1005-1018
[4]
Murray T(2004)The Bcl-2 protein: a prognostic indicator strongly related to ER and PR in breast cancer Bosn J Basic Med Sci 4 5-12
[5]
Xu J(1995)Bcl-2 protein expression in breast cancer in relation to established prognostic factors and other clinicopathological variables Ann Oncol 6 1005-1010
[6]
Thun MJ(2006)Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index Clin Cancer Res 12 2468-2475
[7]
Citron ML(2002)Molecular markers in breast cancer: can we use c-erbB-2, p53, bcl-2 and bax gene expression as prognostic factors? Breast 11 279-285
[8]
Berry DA(2001)Plasma bcl-2 and nitric oxide: possible prognostic role in patients with metastatic breast cancer Med Oncol 18 171-178
[9]
Cirrincione C(1994)Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy Int J Cancer 59 619-628
[10]
Hudis C(1995)Prognostic value of bcl-2 expression in invasive breast cancer Br J Cancer 72 354-360